Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Rhabdoid Tumor × MLN 8237 × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rhabdoid Tumor 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1

Interventions

X-Rays 6 Phantoms, Imaging 6 Magnetic Resonance Spectroscopy 6 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Biopsy 4 Cyclophosphamide 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 etoposide phosphate 2 erdafitinib 2 ensartinib 2 Topotecan 2 Etoposide 2 tazemetostat 1 pembrolizumab 1 olaparib 1 atezolizumab 1 Vincristine 1 Vemurafenib 1 Tiragolumab 1 Temozolomide 1 Sirolimus 1 Radiotherapy 1 Pharmacogenomic Variants 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02114229 2026-03-17

SJATRT

St. Jude Children's Research Hospital

Phase 2 Active not recruiting

Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡